While E-cad expression has been extensively studied in many forms of human cancers, including OSCC [27,30-40], less is known about the expression levels of P-cad in human cancers [23,41-51] and, particularly, in OSCCs in vivo [35,39,40,52]. Here, CDH3 is linked to cancer.